Discontinuation report TOBRAMYCIN INJECTION, USP

Last updated on 2022-01-12 History
Report ID 152485
Drug Identification Number 02382814
Brand name TOBRAMYCIN INJECTION, USP
Common or Proper name Tobramycin injection
Company Name MYLAN PHARMACEUTICALS ULC
Market Status DORMANT
Active Ingredient(s) TOBRAMYCIN
Strength(s) 40MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR
Packaging size 2mL 10 vial, 30mL 1 vial
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-01-06
Remaining supply date 2022-01-06
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Discontinued in shortage ID 6982 & 6979. Last lot 7007753 Expiry October 31, 2016.
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-01-12 French Compare
v1 2022-01-12 English Compare

Showing 1 to 2 of 2